Skip to content

Predictors of recurrence after cryoballoon ablation of atrial fibrillation: A prospective, single-center cohort study

Predictors of recurrence after cryoballoon ablation of atrial fibrillation: A prospective, single-center cohort study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200056733
Enrollment
Unknown
Registered
2022-02-12
Start date
2020-05-01
Completion date
Unknown
Last updated
2023-09-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial fibrillation

Interventions

None listed

Sponsors

Second Hospital of Tianjin Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. AF was confirmed by >= one time of routine 12-lead electrocardiogram or 24-hour Holter electrocardiographic monitoring (Holter) (referred to 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS)); 2. First cryoablation of atrial fibrillation; 3. Age >= 18 years; 4. Left atrial and left atrial appendage thrombus excluded by transesophageal echocardiography (TEE); 5. Patients were regularly followed up by ECG or Holter at 1 month and every 3 months after the procedure; 6. Patients and their families understood the purpose and steps of this study, voluntarily participated in this study, and signed written informed consent; 7. Patients and their families were willing and able to follow the requirements of the plan.

Exclusion criteria

Exclusion criteria: 1. Previous history of catheter ablation of atrial fibrillation.

Design outcomes

Primary

MeasureTime frame
Recurrence of atrial fibrillation;

Secondary

MeasureTime frame
Blood biomarker;Thromboembolism;Bleeding;Cardiovascular death;All-cause mortality;Heart failure;Assessment in quality of life;

Countries

China

Contacts

Public ContactLiu Tong

Second Hospital of Tianjin Medical University

liutongdoc@126.com+86 13902183163

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 6, 2026